BNT162b2 Vaccine Effectiveness in Preventing Asymptomatic Infection With SARS-CoV-2 Virus: A Nationwide Historical Cohort Study

SARS-CoV-2 Transmission From People Without COVID-19 Symptoms

(2021) Michael A. Johansson et al.   JAMA Network Open

Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients

(2021) Sharon Amit et al.   LANCET

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

(2021) Noa Dagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

SARS-CoV-2 Infection after Vaccination in Health Care Workers in California

(2021) Jocelyn Keehner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021

(2021) Mark G. Thompson et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization

(2021) Gabriel Chodick et al.   JAMA Network Open

Characterization of an asymptomatic cohort of SARS-COV-2 infected individuals outside of Wuhan, China

(2020) Yubo Wang et al.   CLINICAL INFECTIOUS DISEASES

Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility

(2020) Melissa M. Arons et al.   NEW ENGLAND JOURNAL OF MEDICINE

A study on infectivity of asymptomatic SARS-CoV-2 carriers

(2020) Ming Gao et al.   RESPIRATORY MEDICINE

Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis

(2020) Diana Buitrago-Garcia et al.   PLOS MEDICINE

Infectivity of asymptomatic versus symptomatic COVID-19

(2020) Andrew A Sayampanathan et al.   LANCET

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE